SCHEMBL20057028

SCHEMBL20057028

CSSC(C)(C#N)CCC(=O)N(C)[C@@H](C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20253987 0.89 — —
SCHEMBL20253988 0.89 — —
SCHEMBL20261381 0.87 — —
SCHEMBL4528423 0.81 — —
SCHEMBL1752303 0.81 — —
SCHEMBL20056991 0.76 NAALAD2 (0.35) —
SCHEMBL26212138 0.75 — —
SCHEMBL21137508 0.75 — —
SCHEMBL20056982 0.75 — —
SCHEMBL20253965 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10449258-B2 Antibody drug conjugate, intermediate, preparation method, pharmaceutical composition and uses thereof XDCEXPLORER (SHANGHAI) CO., LTD. (CN) 2019-10-22 — — US disclosed
US-20180161446-A1 ANTIBODY DRUG CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF XDCEXPLORER (SHANGHAI) CO., LTD. (CN) 2018-06-14 — — US disclosed
US-20180161446-A1 ANTIBODY DRUG CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF XDCEXPLORER (SHANGHAI) CO., LTD. (CN) 2018-06-14 — — US disclosed
EP-3308801-A1 ANTIBODY DRUG CONJUGATE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF XDCExplorer (Shanghai) Co., Ltd. (CN) 2018-04-18 — — EP disclosed
Send feedback